APPLICATION
NDA011120
TYPE
NDA
ORIGINAL APPROVAL
1957-09-18
LATEST ACTION
2001-04-03
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
THORAZINEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 200MG · CAPSULE, EXTENDED RELEASE · ORAL
THORAZINEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 75MG · CAPSULE, EXTENDED RELEASE · ORAL
THORAZINEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 150MG · CAPSULE, EXTENDED RELEASE · ORAL
THORAZINEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 30MG · CAPSULE, EXTENDED RELEASE · ORAL
THORAZINEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 300MG · CAPSULE, EXTENDED RELEASE · ORAL
Approval history
2000-03-27Manufacturing (CMC) · Supplement 85 · standardAP
1998-04-22Labeling · Supplement 81 · standardAP
1996-09-20Manufacturing (CMC) · Supplement 84 · standardAP
1957-09-18Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.